Health economics for non-economists
eBook - PDF

Health economics for non-economists

Principles, methods and pitfalls of health economic evaluations

  1. English
  2. PDF
  3. Available on iOS & Android
eBook - PDF

Health economics for non-economists

Principles, methods and pitfalls of health economic evaluations

About this book

Health economics is about making wise investments in health and health care. The purpose of this book is to make readers familiar with the principles, methods and pitfalls of health economic evaluations. These evaluations help to make choices and set priorities in favour of those investments (for prevention, diagnosis, cure or care) that give the greatest return on health for money spent.The results of these evaluations are increasingly a subject of focus and discussion in scientific journals, at congresses and in health policy making. This book will help everyone who is involved in health and health care to understand the methods used in these evaluations and to interpret their results. In this second edition, with numerous recent examples, attention is also given to relatively new methods (including methods to measure quality of life) and a number of unavoidable trends (such as the use of real world evidence). Readers do not need a basic knowledge of economics.For international orders: https://nolledz.com/product/health-economics-for-non-economists/

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Health economics for non-economists by Lieven Annemans in PDF and/or ePUB format, as well as other popular books in Business & Pharmaceutical, Biotechnology & Healthcare Industry. We have over one million books available in our catalogue for you to explore.
50. 
Annemans 
L. 
Towards 
a 
new 
concept: 
Value 
Informed 
and 
Affordable 
prices 
for 
medicines. 
The 
European 
Files. 
Medicines 
of 
the 
Future. 
2017
51. 
Toumi 
M, 
Jarosławski 
S, 
Sawada 
T, 
Kornfeld 
Å. 
The 
Use 
of 
Surrogate 
and 
Patient-Relevant 
Endpoints 
in 
Outcomes-Based 
Market 
Access 
Agreements 
: 
Current 
Debate. 
Appl 
Health 
Econ 
Health 
Policy. 
2017 
Feb;15(1):5-11.
52. 
Ferrario 
A, 
Kanavos 
P. 
Dealing 
with 
uncertainty 
and 
high 
prices 
of 
new 
medicines: 
a 
comparative 
analysis 
of 
the 
use 
of 
managed 
entry 
agreements 
in 
Belgium, 
England, 
the 
Netherlands 
and 
Sweden. 
Soc 
Sci 
Med. 
2015 
Jan;124:39-47.
53. 
Huybrechts 
M, 
Hulstaert 
F, 
Neyt 
M, 
Vrijens 
F, 
Ramaekers 
D. 
Trastuzumab 
in 
Early 
Stage 
Breast 
Cancer. 
Health 
Technology 
Assessment 
(HTA). 
Brussels: 
Belgian 
Health 
Care 
Knowledge 
Centre 
(KCE); 
2006. 
KCE 
reports 
34C. 
D/2006/10.273/25.
527527_113 
Health 
economics.indb 
136
30/05/2018 
10:39:11

Table of contents